PetVivo Holdings is a biomedical device company dedicated to advancing animal health through innovation. The company focuses on the manufacturing, commercialization, and licensing of medical devices and therapeutics for companion animals. Its core product, Kush Canine, is an intra-articular injectable device designed to treat osteoarthritis in dogs using proprietary micro-cushion technology. PetVivo's mission is to improve the quality of life for pets by providing cutting-edge solutions for joint pain and lameness.
PetVivo has made significant strides in the veterinary field with its innovative approach to treating osteoarthritis. The company's patented technology has garnered attention for its effectiveness and biocompatibility, positioning PetVivo as a leader in veterinary medical devices. Through its commitment to research and development, PetVivo continues to impact the lives of pets and their owners positively, ensuring better health outcomes for companion animals.
